Default Category
-
Tale of Two Electronic Components Distributors (Spanish Version)
Raman, Ananth; Rao, Bharat P.Case HBS-604S15Service and Operations ManagementDiscute el papel de los intermediarios de distribución en la industria de componentes electrónicos, y describe las operaciones en dos de estos distribuidores. Sirve como un vehículo para discutir las funciones proporcionadas por los distribuidores en el canal. También permite a los estudiantes a entender las diferencias entre los distribuidores y discutir cómo cada uno de ellos va a hacer frente a cuestiones como la consolidación y el rápido crec...Starting at €8.20
-
Supply Chain Optimization at Hugo Boss (B) - The M-Ratio (Spanish Version)
Raman, Ananth; Kanji, Zahra; DeHoratius, NicoleCase HBS-610S09Service and Operations ManagementEvaluamos el impacto de un piloto de la cadena de suministro en práctica de Hugo Boss. Este piloto implicaba alterar la forma en que los pedidos de Hugo Boss de sus proveedores. Exploramos el desafío de evaluar el impacto del cambio de cadena de suministro, la relación entre el rendimiento operativo y resultados de la empresa, y la relación entre las ventas, el inventario, y la disponibilidad de los productos.Starting at €5.74
-
Improving the Patient Experience (Spanish version)
Raman, Ananth; Tucker, AnitaCase HBS-615S02Service and Operations ManagementHealthcare has traditionally focused on medical outcomes and financial performance. The big question is always, "How much is it going to cost?" What would happen, though, if healthcare also considered the question of "How does the patient feel?" This case looks at the Cleveland Clinic's attempt to answer the latter question by attempting to institutionalize empathy as part of its delivery of care.Starting at €8.20
-
Terumo (C) (Spanish Version)
Godes, David B.; Egawa, Masako; Yamazaki, MayukaCase HBS-510S03MarketingPara maximizar su eficacia, los casos de color deben imprimirse en color. Este caso proporciona una información actualizada sobre la decisión de la empresa en cuanto a su estrategia de ventas para sus productos de EE.UU. catéter y el progreso del paquete de soluciones. También se analiza la expansión de la firma del "Pranex médica", una formación y reunión espacio único que ofrece facilidad para médicos y enfermeras.Starting at €5.74
-
Sales Force Integration at FedEx (A) (Spanish version)
Godes, David B.Case HBS-513S26MarketingFederal Express' (FedEx) recent acquisition of RPS--a ground delivery firm--gave the firm the potential to offer a single source for a client's delivery needs. However, to deliver on this potential, the firm needed to deliver the integrated solution through a single sales force. This integration required the solution of many issues, none more important than the formulation of a new compensation plan that not only determined the sales force's effo...Starting at €8.20
-
Sales Force Integration at FedEx (D) (Spanish version)
Godes, David B.Case HBS-513S29MarketingAn abstract is not available for this product.Starting at €5.74
-
ENSR International, Teaching Note
Godes, David B.Teaching Note HBS-503094-EMarketingTeaching Note for (9-503-075).Starting at €0.00
-
Terumo (A)
Godes, David B.; Egawa, Masako; Yamazaki, MayukaCase HBS-508068-EMarketingTo maximize their effectiveness, color cases should be printed in color. Terumo faces two challenges: how to sell its catheter products in the U.S. and its new "Solution Pack" in its domestic market, Japan. The case provides rich detail on the firm's evolution from a manufacturer of thermometers to a seller of commodity products like syringes to a diversified firm offering a range of advanced products-catheters and graphs, for example-in addition...Starting at €8.20
-
Terumo (B)
Godes, David B.; Egawa, Masako; Yamazaki, MayukaCase HBS-508069-EMarketingThis case provides an update on the firm's decision regarding its U.S. sales strategy for its catheter products and the progress of Solution Pack.Starting at €5.74
-
Merck: Investing in Science-Based Business (Abridged)
Raman, Ananth; Maurer, IngaCase HBS-611027-EService and Operations ManagementRay Gilmartin faces a dilemma. His company's credibility has been damaged by the recent withdrawal of Vioxx, a multi-billion dollar drug. Moreover, the withdrawal of Vioxx would imply that Merck would fail to meet analysts' earnings expectations for 2005 unless Gilmartin cuts the R&D budget. Cutting the budget might hurt morale and productivity in Merck labs.Starting at €8.20